Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

C+D campaigns for small pharmacy funding

Pharmacists and patients can download a letter to alert their MP to the plight of low volume pharmacies waiting to find out whether their top-up funding will continue beyond next month

C+D has launched a campaign to secure continued funding for low volume pharmacies once a national scheme ends this month.

Only 16 of the 73 pharmacies who receive the additional NHS England funding – designed to support 'essential' small businesses at least 1km from another pharmacy – have been assured by their NHS England area team that they will continue to be financially supported once the current scheme ends on March 31, health minister Jane Ellison MP said on Monday (March 3).

Pharmacies on the scheme – the Essential Small Pharmacies Local Pharmaceutical Services (ESPLPS) scheme – have told C+D they would struggle to survive without this extra funding.

To support these businesses, C+D has drafted a letter for pharmacists and patients to send to their MP, urging them to persuade their local NHS England area team to quickly reach a funding decision for affected pharmacies in their constituency.

C+D has also set up a dedicated campaign page, which includes case studies of pharmacies who are still awaiting a funding decision. This will be updated throughout the month.

Download a copy of the letter here.

Is your pharmacy at risk of having its funding cut?

Related Content

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD017643

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel